Literature DB >> 11035420

Illness intrusiveness explains race-related quality-of-life differences among women with systemic lupus erythematosus.

G M Devins1, S M Edworthy.   

Abstract

Our objective was to investigate whether quality of life in systemic lupus erythematosus (SLE) differs across ethnoracial groups and to identify factors that may explain race-related differences. Self-administered questionnaire data from 335 White, 40 Black, and 30 Asian women with SLE were obtained from a multi-center database. Measures assessed illness intrusiveness, psychological well-being, depressive symptoms, musculoskeletal pain, and learned helplessness. Extent of SLE disease activity was indexed by self-reported functional-system involvement. Educational attainment was indicated by number of years in school. Principal-components analysis reduced the four psychosocial measures to a single factor score. This represented psychosocial well-being In path analysis. Psychosocial well-being differed significantly across the three groups, with Whites reporting the highest, and Blacks the lowest, levels. Path analysis indicated that illness intrusiveness accounted for this race-related difference. Although disease activity was significantly associated with psychosocial well-being, it did not differ across ethnoracial groups. Illness intrusiveness and educational attainment emerged as independent mediators of the race-related difference in psychosocial well-being. We conclude that race-related quality-of-life differences exist among women with SLE and are mediated independently by illness intrusiveness and educational attainment.

Entities:  

Mesh:

Year:  2000        PMID: 11035420     DOI: 10.1177/096120330000900710

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

1.  Do ongoing lifestyle disruptions differ across cancer types after the conclusion of cancer treatment?

Authors:  Kenneth Mah; Andrea Bezjak; D Andrew Loblaw; Andrew Gotowiec; Gerald M Devins
Journal:  J Cancer Surviv       Date:  2010-12-21       Impact factor: 4.442

Review 2.  Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

3.  Factor structure of the Korean version of illness intrusiveness rating scale: cross-cultural implications.

Authors:  Daeho Kim; Kwang-iel Kim; Haewon Lee; Joonho Choi; Yong-Chon Park
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

4.  Predictors of self-reported health-related quality of life in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Vibeke Strand; Hong Fang; Jawali Jaranilla; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2013-05-16       Impact factor: 7.580

Review 5.  Living with systemic lupus erythematosus in the developing world.

Authors:  A Phuti; M Schneider; M Tikly; B Hodkinson
Journal:  Rheumatol Int       Date:  2018-03-26       Impact factor: 2.631

Review 6.  Lupus nephritis.

Authors:  Hans-Joachim Anders; Ramesh Saxena; Ming-Hui Zhao; Ioannis Parodis; Jane E Salmon; Chandra Mohan
Journal:  Nat Rev Dis Primers       Date:  2020-01-23       Impact factor: 52.329

7.  Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study.

Authors:  M Scolnik; J Marin; S M Valeiras; M F Marchese; A S Talani; N L Avellaneda; A Etchepare; P Etchepare; M S Plou; E R Soriano
Journal:  Lupus Sci Med       Date:  2014-06-05

Review 8.  Update on lupus epidemiology: advancing health disparities research through the study of minority populations.

Authors:  Cristina Drenkard; S Sam Lim
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

9.  Structural and health system determinants of health outcomes in systemic lupus erythematosus: Understanding the mechanisms underlying health disparities.

Authors:  Jerik Leung; Lily McMorrow; Rhonda BeLue; Elizabeth A Baker
Journal:  Front Public Health       Date:  2022-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.